Aurora Spine to Participate at SBNS in UK

Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will be participating at the Society of British Neurological Surgeons (SBNS) 2014. The Coventry Trade Show Conference, hosted by University Hospitals Coventry and Warwickshire NHS Trust, will be held at the Heritage Motor Centre, Warwickshire, United Kingdom from Wednesday, September 17th to Friday, September 19th, 2014.

"Aurora Spine is please to exhibit this year at the Society of British Neurological Surgeons at the Heritage Motor Centre in Coventry," said Sven Claes, Aurora's International Product Director. "We will display our new cervical cage 'Discovery', which features Aurora's new TiNano™ technology."

TiNano is Aurora Spine's titanium plasma spray coating on PEEK-OPTIMA interbody cages allowing for the possibility of bone ongrowth due to its porous structure. Titanium plasma spray coating has been developed to increase the possibility for stronger bone-implant interface, which could lead to less complications and faster healing. Aurora Spine's other minimally invasive technologies, including the ZIP ULTRA™ MIS Interspinous Fusion System and the TiNano MIS Interbody Fusion System portfolio will be on display at our booth #12.

The purpose of the SBNS is the study and advancement of Neurosurgery, achieved through the scientific meetings of the society, through publications arising from deliberations about aspects of Neurosurgical practice and delivery of Neurosurgical services. The Society promotes safe and effective Neurosurgical treatments for patients throughout Great Britain and Ireland.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of the Aurora Spine's products. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Eric Fronk

Chief Financial Officer

(760) 424-2004

Christian Flores